Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Other Non-Current Assets: 2023-2024

Historic Other Non-Current Assets for Mereo BioPharma Group (MREO) over the last 2 years, with Dec 2024 value amounting to $378,000.

  • Mereo BioPharma Group's Other Non-Current Assets fell 9.84% to $394,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $394,000, marking a year-over-year decrease of 9.84%. This contributed to the annual value of $378,000 for FY2024, which is 38.54% down from last year.
  • Mereo BioPharma Group's Other Non-Current Assets amounted to $378,000 in FY2024, which was down 38.54% from $615,000 recorded in FY2023.
  • Mereo BioPharma Group's Other Non-Current Assets' 5-year high stood at $615,000 during FY2023, with a 5-year trough of $378,000 in FY2024.
  • Moreover, its 2-year median value for Other Non-Current Assets was $496,500 (2023), whereas its average is $496,500.
  • Data for Mereo BioPharma Group's Other Non-Current Assets shows a maximum YoY crashed of 38.54% (in 2024) over the last 5 years.
  • Over the past 2 years, Mereo BioPharma Group's Other Non-Current Assets (Yearly) stood at $615,000 in 2023, then crashed by 38.54% to $378,000 in 2024.